Rivaroxaban (Xarelto) Does Not Cause Anxiety or Teeth Clenching
Based on available evidence, rivaroxaban (Xarelto) is not associated with anxiety or teeth clenching (bruxism) as recognized adverse effects. These symptoms are not documented in FDA labeling, clinical guidelines, or major clinical trials of this anticoagulant.
Evidence Review
FDA-Approved Adverse Effects
The FDA drug label for Xarelto does not list anxiety or bruxism among its adverse reactions 1. The documented side effects focus primarily on:
- Bleeding complications (major and minor bleeding)
- Gastrointestinal effects (particularly lower GI bleeding, more common than with warfarin)
- Hepatic effects (elevated liver enzymes, rare hepatic failure)
- Cardiovascular events (thromboembolism if discontinued abruptly)
Clinical Trial Data
Major clinical trials evaluating rivaroxaban (ROCKET-AF, EINSTEIN studies) did not identify anxiety or teeth clenching as adverse events 2, 3, 4. The focus of safety monitoring in these trials was on bleeding risk, thrombotic events, and mortality outcomes.
Guideline Perspectives
International guidelines on novel oral anticoagulants (NOACs) emphasize monitoring for 5:
- Bleeding complications
- Drug-drug interactions (particularly with CYP3A4 and P-glycoprotein inhibitors/inducers)
- Renal function deterioration
- Hepatic dysfunction
No guideline mentions psychiatric or dental/jaw symptoms as concerns with rivaroxaban therapy.
Important Considerations
What Could Explain These Symptoms?
If you're experiencing anxiety or teeth clenching while taking rivaroxaban, consider:
Underlying condition being treated: Atrial fibrillation, deep vein thrombosis, and pulmonary embolism can themselves cause anxiety due to the stress of having a serious medical condition
Concomitant medications: Review other medications, as many drugs can cause anxiety or bruxism:
- Antidepressants (SSRIs, SNRIs)
- Stimulants
- Certain antihypertensives
Psychological stress: The burden of taking anticoagulation therapy and fear of bleeding or clotting complications can manifest as anxiety 6
Unrelated conditions: Anxiety disorders and bruxism are common in the general population and may coincidentally occur during rivaroxaban therapy 7
Research Context
One experimental animal study suggested rivaroxaban might have anti-depressant effects through modulation of inflammatory pathways 6, which is opposite to causing anxiety. However, this was a preclinical study in rats and does not translate to clinical recommendations.
Clinical Recommendation
If experiencing anxiety or teeth clenching while on rivaroxaban:
- Do not attribute these symptoms to rivaroxaban without investigating other causes
- Evaluate for anxiety disorders, sleep disorders, or stress-related conditions
- Review all concomitant medications for potential causative agents
- Consider dental evaluation for bruxism (may need night guard)
- Do not discontinue rivaroxaban without consulting your physician, as abrupt cessation increases thrombotic risk 8, 4
Continue rivaroxaban as prescribed unless your physician identifies a specific contraindication or adverse effect requiring discontinuation 5.